Fonte: Journal of clinical lipidology. Unidade: FM
Assuntos: DISLIPIDEMIAS, FÁRMACOS (SISTEMA CARDIOVASCULAR), DOENÇAS CARDIOVASCULARES, FATORES DE RISCO
ABNT
LOTUFO, Paulo Andrade et al. Prevalence, awareness, treatment, and control of high low-density lipoprotein cholesterol in Brazil: baseline of the Brazilian Longitudinal Study of Adult Health (ELSA-BRASIL). Journal of clinical lipidology, n. 03, p. 568-576, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.jacl.2015.12.029. Acesso em: 30 set. 2024.APA
Lotufo, P. A., Santos Filho, R. D. dos, Figueiredo, R. M., Pereira, A. C., Mill, J. G., Alvim, S. M., et al. (2016). Prevalence, awareness, treatment, and control of high low-density lipoprotein cholesterol in Brazil: baseline of the Brazilian Longitudinal Study of Adult Health (ELSA-BRASIL). Journal of clinical lipidology, ( 03), 568-576. doi:10.1016/j.jacl.2015.12.029NLM
Lotufo PA, Santos Filho RD dos, Figueiredo RM, Pereira AC, Mill JG, Alvim SM, Fonseca MJ, Almeida MC, Molina C, Chor D, Schmidt MI, Ribeiro AL, Duncan BB, Benseñor IJM. Prevalence, awareness, treatment, and control of high low-density lipoprotein cholesterol in Brazil: baseline of the Brazilian Longitudinal Study of Adult Health (ELSA-BRASIL) [Internet]. Journal of clinical lipidology. 2016 ;( 03): 568-576.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.jacl.2015.12.029Vancouver
Lotufo PA, Santos Filho RD dos, Figueiredo RM, Pereira AC, Mill JG, Alvim SM, Fonseca MJ, Almeida MC, Molina C, Chor D, Schmidt MI, Ribeiro AL, Duncan BB, Benseñor IJM. Prevalence, awareness, treatment, and control of high low-density lipoprotein cholesterol in Brazil: baseline of the Brazilian Longitudinal Study of Adult Health (ELSA-BRASIL) [Internet]. Journal of clinical lipidology. 2016 ;( 03): 568-576.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.jacl.2015.12.029